Steven G. Gray
Impact in
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 1%
- Histone Deacetylase Inhibitors Research
- Epigenetics and DNA Methylation
- Circular RNAs in diseases
- RNA modifications and cancer
Papers in
-
- Cancer-related molecular mechanisms research 15
- Cancer, Hypoxia, and Metabolism 13
-
- Histone Deacetylase Inhibitors Research 28
- Epigenetics and DNA Methylation 28
- RNA modifications and cancer 18
- Protein Degradation and Inhibitors 10
- Co-authors
- Ron BrookmeyerClaudia H. KawasTomas J. EkströmStephen P. FinnKenneth J. O’ByrneAdam S. KibelWilliam G. KaelinOthon Iliopoulos
- Journals
- Lung Cancer (13 papers)Journal of Thoracic Oncology (7 papers)Cancers (6 papers)International Journal of Oncology (6 papers)Scientific Reports (5 papers)
- Partner nations
- IrelandUnited StatesAustralia
In The Last Decade
Steven G. Gray
175 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 179
- Cancer Research 2.1k
- Molecular Biology 4.5k
- Geriatrics and Gerontology 225
- Psychiatry and Mental health 831
- Physiology 1.3k
Countries citing papers authored by Steven G. Gray
This map shows the geographic impact of Steven G. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven G. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven G. Gray more than expected).
Fields of papers citing papers by Steven G. Gray
This network shows the impact of papers produced by Steven G. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven G. Gray. The network helps show where Steven G. Gray may publish in the future.
Co-authors
The 25 scholars most cited alongside Steven G. Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 47 | |
| 2 | 2023 | 1 | |
| 3 | 2021 | 44 | |
| 4 | 2021 | 21 | |
| 5 | 2019 | 1 | |
| 6 | 2019 | 26 | |
| 7 | 2018 | 21 | |
| 8 | Lung cancer stem cells: The root of resistance | 2016 | 2 |
| 9 | Mutational analysis of the insulin‑like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients | 2015 | 1 |
| 10 | 2013 | 2 | |
| 11 | 2012 | 30 | |
| 12 | 2012 | 29 | |
| 13 | 2011 | 23 | |
| 14 | Targeting histone deacetylases for the treatment of disease : Epigenetics Review Series | 2009 | 1 |
| 15 | Targeting histone deacetylases for the treatment of immune, endocrine and metabolic disorders | 2009 | 1 |
| 16 | 2006 | 12 | |
| 17 | Mice Lacking the Transcriptional Repressor KLF15 Show a Limited, but Statistically Significant Increase in Ectopic Rhodopsin Expressing Cells | 2005 | 1 |
| 18 | 2005 | 230 | |
| 19 | 1998 | 15 | |
| 20 | 1994 | 15 |
About Steven G. Gray
Steven G. Gray is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Speech and Hearing, having authored 178 papers that have together received 8.5k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (28 papers), Epigenetics and DNA Methylation (28 papers), RNA modifications and cancer (18 papers), Occupational and environmental lung diseases (17 papers), Cancer-related molecular mechanisms research (15 papers), Cancer, Hypoxia, and Metabolism (13 papers), Lung Cancer Treatments and Mutations (10 papers) and Protein Degradation and Inhibitors (10 papers). The work is most often cited by research in Cancer Research (2.1k citations), Molecular Biology (4.5k citations), Geriatrics and Gerontology (225 citations), Psychiatry and Mental health (831 citations) and Physiology (1.3k citations). Steven G. Gray has collaborated with scholars based in Ireland, United States and Australia. Frequent co-authors include Ron Brookmeyer, Claudia H. Kawas, Tomas J. Ekström, Stephen P. Finn, Kenneth J. O’Byrne, Adam S. Kibel, William G. Kaelin, Othon Iliopoulos, Anne‐Marie Baird and Sinéad Cuffe. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, Cancers, International Journal of Oncology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.